Literature DB >> 26091060

A Worksite Occupational Health Clinic-Based Diabetes Mellitus Management Program.

Wayne N Burton1,2, Chin-Yu Chen3, Xingquan Li3, Denise Erickson2, Maureen McCluskey2, Alyssa Schultz3.   

Abstract

This study is an analysis of a workplace diabetes management program offered to employees of a Fortune 100 financial services corporation located in the United States. The 12-month worksite-based educational program was for employees who were at risk for diabetes, had prediabetes, or were diagnosed with diabetes. This employed population, with health benefits, generally had acceptable control of their diabetes at the start of the program. They statistically improved most self-efficacy measures, but improvement in biometric tests at 6 and 12 months were not significantly different from baseline. Mean hemoglobin A1c at baseline, 6 months, and 12 months was 7.2%, 7.2%, and 7.3%, respectively. At 12 months, about 40% of preprogram survey participants completed all screenings and the post-program questionnaire. Disease management programs at the workplace can be an important component in helping employees enhance their knowledge of diabetes and maintain and improve their health.

Entities:  

Mesh:

Year:  2015        PMID: 26091060     DOI: 10.1089/pop.2014.0141

Source DB:  PubMed          Journal:  Popul Health Manag        ISSN: 1942-7891            Impact factor:   2.459


  2 in total

Review 1.  Workplace Interventions to Prevent Type 2 Diabetes Mellitus: a Narrative Review.

Authors:  Dina Hafez; Allison Fedewa; Margaret Moran; Matthew O'Brien; Ronald Ackermann; Jeffrey T Kullgren
Journal:  Curr Diab Rep       Date:  2017-02       Impact factor: 4.810

2.  Interventions for the prevention of risk factors and incidence of type 2 diabetes in the work environment: a systematic review.

Authors:  Jorge Inolopú; Nélida Hilario-Huapaya; Martín Alonso Tantaleán-Del-Águila; Yamilee Hurtado-Roca; Cesar Ugarte-Gil
Journal:  Rev Saude Publica       Date:  2019-12-02       Impact factor: 2.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.